Hospital-acquired anemia


Clinical question: Is hospital acquired anemia associated with increased postdischarge adverse outcomes?

Background: Hospital acquired anemia (HAA) is defined as the development of anemia during the course of a hospitalization when starting with a normal hemoglobin on admission. The incidence of HAA is at least 25% when using the last hemoglobin prior to discharge as the index value. HAA is felt to be potentially preventable and usually iatrogenic due to phlebotomy.

Dr. Jeremiah Newsom, a hospitalist at Ochsner Health System, New Orleans

Dr. Jeremiah Newsom

Study design: Observational cohort study.

Setting: Six northern Texas hospitals.

Synopsis: There were 11,309 index hospitalizations with a median hematocrit value on admission of 40.6 g/dL. The authors defined HAA as a normal hematocrit value within the first 24 hours of admission and a hematocrit value lower than the WHO sex-specific cut points at the time of discharge: mild HAA (hematocrit greater than 33% and less than 36% in women, greater than 33% and less than 40% in men), moderate HAA (greater than 27% and less than 33%), and severe HAA (less than 27%). Mild HAA occurred in 21.6% of patients, with 10.1% of patients developing moderate HAA, and 1.4% developing severe HAA (85% underwent major procedure, diagnosis of hemorrhage or coagulation/hemorrhagic disorder). Predictors of developing moderate/severe HAA included undergoing a major diagnostic or therapeutic procedure, female sex, elective admission, hospital LOS, BUN to creatinine ratio greater than 20:1, and serum creatinine on admission. Development of severe HAA was associated with a 41% increase in the odds of 30-day readmission and a 39% increase in the odds of the composite outcome (30-day mortality and 30-day readmission).

Bottom line: Severe HAA had significant increased odds of 30-day readmission and mortality, but might not be as preventable as initially thought given the frequency of major procedures and hemorrhage in those that developed severe HAA.

Citation: Makam AN, Nguyen OK, Clark C, Halm EA. Incidence, predictors, and outcomes of hospital-acquired anemia. J Hosp Med. 2017;12(5):317-22.

Dr. Newsom is a hospitalist at Ochsner Health System, New Orleans.

Recommended Reading

Increased death rate with platelets for aspirin/clopidogrel GI bleed
The Hospitalist
Blood thinning with bioprosthetic valves
The Hospitalist
Taking the hammer to sickle pain crises
The Hospitalist
What are indications, complications of acute blood transfusions in sickle cell anemia? Key Points Additional Reading
The Hospitalist
Consider switch to clopidogrel for DAPT early post ACS
The Hospitalist
Application of the MASCC and CISNE risk-stratification scores to identify low-risk febrile neutropenic patients in the emergency department
The Hospitalist
Low-dose aspirin bests dual-antiplatelet therapy in TAVR
The Hospitalist
Idarucizumab reversed dabigatran completely and rapidly in study
The Hospitalist
   Comments ()